Kapiva, an Ayurveda-focused wellness and nutrition company, reported a 50% year-on-year jump in operating revenue for FY25 to Rs 342 crore, driven by heightened consumer demand for natural health products and an expanded presence across digital marketplaces. Total income, including other receipts, approached Rs 349 crore for the year ended March 31, 2025.
Business profile and drivers of growth
Founded in 2015, Kapiva specialises in Ayurvedic and plant‑based offerings targeting lifestyle conditions such as diabetes, thyroid imbalance, liver health, hormonal wellness, digestion, immunity and sports nutrition. The FY25 revenue surge reflects both stronger market demand for wellness and the company’s intensified push on e‑commerce, direct‑to‑consumer channels and marketplace partnerships.
Advertising becomes the single largest expense
Kapiva invested heavily in marketing during FY25, spending Rs 188 crore on advertising and promotions—about a 53% increase from the prior year. Advertising accounted for nearly 45% of total expenses, making it the company’s biggest cost item as it sought rapid scale in a crowded nutraceutical and wellness market.
The elevated marketing outlay mirrors competitive pressures across the Indian health and wellness sector, where legacy Ayurvedic houses and digitally native startups alike are vying for customer acquisition and brand recall.
Cost pressures and profitability
Total expenditure rose to Rs 418 crore in FY25 from Rs 290 crore in FY24, reflecting broader expansion across cost lines. The cost of materials consumed climbed to Rs 97 crore, while employee benefit expenses increased to Rs 59 crore as Kapiva bolstered teams across operations, sales and marketing. Logistics and transportation costs were Rs 22 crore, and legal and professional fees rose to about Rs 16 crore.
Higher spending contributed to a wider net loss of Rs 69 crore in FY25, up from Rs 56 crore a year earlier. Despite the increased loss, unit economics showed marginal improvement: Kapiva spent Rs 1.22 to generate every Rs 1 of operating revenue, compared with Rs 1.27 in FY24.
Liquidity and funding
The company maintained a solid cash position at the close of FY25, with cash and bank balances of Rs 139 crore and current assets of roughly Rs 199 crore. That liquidity, supported by about $90 million of cumulative funding including a sizeable Series D, gives Kapiva room to continue investing in marketing, product development and supply‑chain expansion.
Outlook
Kapiva’s FY25 results reflect a common pattern among Indian direct‑to‑consumer brands: robust top‑line growth funded by elevated marketing investment. Moving into FY26, the key metrics to watch will be whether the company can sustain revenue momentum while reining in acquisition costs and narrowing losses, as investor emphasis shifts toward sustainable growth and financial discipline in the startup ecosystem.
